Health Care

See who is on the move at Lamoureaux Pagano Associates, AAFCPA's, Fidelity Bank, and more.

Regulators and industry groups are hopeful lawmakers will prioritize action to slow down sharply rising costs for health care services, medications and other major needs after the COVID-19 pandemic exacerbated long-standing pressure points and ripped open new affordability issues.

Following the unexpected death of Dr. Michael Green, UMass Chan has selected two faculty members to fill the void left by the former professor and vice provost for strategic research initiatives.

The Gov. Maura Healey Administration said Wednesday the state’s public health emergency over the coronavirus pandemic will end on May 11, the same day as the federal COVID-19 emergency will expire.

Per capita healthcare expenditures in Massachusetts rose 9 percent in 2021, following a 2.3 percent drop in 2020.

Marlborough-based pharmaceutical company TheracosBio appointed Jeff McGroarty as its first full-time chief financial officer. His appointment comes following regulatory approval of a new diabetes drug, TheracosBio’s first commercial product.

Hundreds of thousands people are expected to be booted off the state-run health insurance program over the next year as federal continuous coverage requirements for Medicaid in place since March 2020 expire and the state goes through the required redetermination process for the first time since the pandemic began.

Marlborough medical device company Candela Corp. has received clearance from the U.S. Food & Drug Administration to use the company’s laster system to treat Melasma, a skin condition frequently arising during pregnancy, among other times.

Hiring remains a challenge at companies still focused on growth and recruitment, in part due to the high cost of living in Massachusetts.

UMass Chan Medical School is consolidating its workforce at MassBiologics, its Boston-based biologics and vaccine manufacturing arm. The affected positions will be eliminated in 60 days.